Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated, United States

Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 6074 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 6074 years with high risk conditions are calculated using data from the National Immunization SurveyAdult COVID Module (NISACM) (https://www.cdc.gov/nis/about/index.html). In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged 60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 6074 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older. Read less